Synthetic Biologics Forum: Community User: Fee

https://beststocks.com/theriva-biologics-makes-strides-in-virage-pro/

☕️😎🔥

👀

Theriva shares rally amid FDA orphan drug designation for lead product https://seekingalpha.com/news/3983444-theriva-shares-rally-amid-fda-orphan-drug-designation-for-lead-product Theriva Biologics (NYSE:TOVX) said that its lead drug candidate VCN-01 has received orphan drug status from the FDA in the treatment of pancreatic cancer.  VCN-01 also has an orphan drug designation for the treatment of retinoblastoma. According to Theriva's website, the product is in Phase 2 testing for pancreatic cancer and Phase 1 for retinoblastoma.  ...

https://finance.yahoo.com/news/theriva-biologics-announces-orphan-drug-201000048.html

https://www.globenewswire.com/news-release/2023/05/11/2666648/0/en/Theriva-Biologics-Reports-First-Quarter-2023-Operational-Highlights-and-Financial-Results.html

https://www.globenewswire.com/news-release/2023/04/13/2646140/0/en/Theriva-Biologics-Announces-Presentation-of-Data-from-Cohort-1-of-the-Phase-1b-2a-Clinical-Trial-of-SYN-004-ribaxamase-in-Allogeneic-Hematopoietic-Cell-Transplant-Recipients.html

https://www.globenewswire.com/news-release/2023/03/30/2637573/0/en/Theriva-Biologics-Reports-Fourth-Quarter-and-Full-Year-2022-Operational-Highlights-and-Financial-Results.html

Theriva Biologics Inc - On March 8, Audit Committee Of Co Concluded That Certain Of Co's Financial Statements Should No Longer Be Relied Upon https://kalkinemedia.com/us/amp/business-news/pharma/brief-theriva-biologics-inc-on-march-8-audit-committee-of-co-concluded-that-certain-of-cos-financial-statements-should-no-longer-be-relied-upon

https://www.marketscreener.com/amp/quote/stock/THERIVA-BIOLOGICS-INC-45286486/news/Theriva-Biologics-Non-Reliance-on-Previously-Issued-Financial-Report-Form-8-K-43217259/

https://www.globenewswire.com/news-release/2023/02/16/2610106/0/en/Theriva-Biologics-Announces-Presentation-of-Safety-and-Pharmacokinetic-Data-from-Cohort-1-of-the-Phase-1b-2a-Clinical-Trial-of-SYN-004-ribaxamase-in-Allogeneic-Hematopoietic-Cell-T.html

http://insiderbuyingselling.com/?t=TOVX

...heute immerhin...

Mal schauen, ob sie heute den Dollar schafft...

https://whatstocksmove.com/tovx-theriva-biologics-receives-notice-of-allowance-for-patent-for-treatment-of-radiation-disorders/1000/ Theriva Biologics Receives Notice of Allowance for Patent for Treatment of Radiation Disorders Theriva Biologics (NYSE: TOVX) received a Notice of Allowance for its US patent application 16/982,211 titled “ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS”

🍀